EDGAR Filing Documents for 0001564590-22-016102

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001564590-22-016102

Filing Date

2022-04-27

Accepted

2022-04-27 16:38:17

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	pstx-defa14a_20220616.htm	DEFA14A	15565
2	GRAPHIC	gl1e0dmmxo4i000001.jpg	GRAPHIC	76491
3	GRAPHIC	gl1e0dmmxo4i000002.jpg	GRAPHIC	22891
	Complete submission text file	0001564590-22-016102.txt		153684

Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121

Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100

Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39376 | Film No.: 22860381
SIC: 2836 Biological Products, (No Diagnostic Substances)